中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
CHINESE JOURNAL OF ANESTHESIOLOGY
2009年
11期
1013-1015
,共3页
韩志岩%蒋鑫%王伟鹏%荆志成%李立环
韓誌巖%蔣鑫%王偉鵬%荊誌成%李立環
한지암%장흠%왕위붕%형지성%리립배
伊洛前列素%高血压%肺性%心脏缺损%先天性%心肺转流术
伊洛前列素%高血壓%肺性%心髒缺損%先天性%心肺轉流術
이락전렬소%고혈압%폐성%심장결손%선천성%심폐전류술
Iloprost%Hypertension%pulmonary%Heart defects%congenital%Cardiopulmonary bypass
目的 评价吸入伊洛前列素对先天性心脏病矫治术患者体外循环后肺动脉高压的影响.方法 选择体外循环下先天性心脏病矫治术患者58例,年龄14~60岁,气管插管后右颈内静脉置漂浮导管监测肺动脉压.体外循环下行先天性心脏病矫治术,体外循环结束后平均肺动脉压仍>25mm Hg,此时通过压缩式雾化器吸入伊洛前列素10μg,于吸药前即刻(T_0)、吸药完毕后即刻,吸药完毕后5、15、30和60min时监测心率、右房压、肺小动脉楔压、平均肺动脉压、平均桡动脉压、肺血管阻力和体循环阻力、心输出量及混合静脉血氧饱和度.结果 先天性心脏病矫治术患者体外循环后存在肺动脉高压患者28例.与吸药前即刻比较,吸药完毕后各时点患者平均肺动脉压和肺血管阻力明显降低,心输出量和吸药完毕后即刻、5 min时混合静脉血氧饱和度明显升高(P<0.05或0.01).结论 体外循环结束后吸入伊洛前列素可有效降低先天性心脏病矫治术患者肺动脉压和肺血管阻力,有助于患者安全、顺利地脱离体外循环.
目的 評價吸入伊洛前列素對先天性心髒病矯治術患者體外循環後肺動脈高壓的影響.方法 選擇體外循環下先天性心髒病矯治術患者58例,年齡14~60歲,氣管插管後右頸內靜脈置漂浮導管鑑測肺動脈壓.體外循環下行先天性心髒病矯治術,體外循環結束後平均肺動脈壓仍>25mm Hg,此時通過壓縮式霧化器吸入伊洛前列素10μg,于吸藥前即刻(T_0)、吸藥完畢後即刻,吸藥完畢後5、15、30和60min時鑑測心率、右房壓、肺小動脈楔壓、平均肺動脈壓、平均橈動脈壓、肺血管阻力和體循環阻力、心輸齣量及混閤靜脈血氧飽和度.結果 先天性心髒病矯治術患者體外循環後存在肺動脈高壓患者28例.與吸藥前即刻比較,吸藥完畢後各時點患者平均肺動脈壓和肺血管阻力明顯降低,心輸齣量和吸藥完畢後即刻、5 min時混閤靜脈血氧飽和度明顯升高(P<0.05或0.01).結論 體外循環結束後吸入伊洛前列素可有效降低先天性心髒病矯治術患者肺動脈壓和肺血管阻力,有助于患者安全、順利地脫離體外循環.
목적 평개흡입이락전렬소대선천성심장병교치술환자체외순배후폐동맥고압적영향.방법 선택체외순배하선천성심장병교치술환자58례,년령14~60세,기관삽관후우경내정맥치표부도관감측폐동맥압.체외순배하행선천성심장병교치술,체외순배결속후평균폐동맥압잉>25mm Hg,차시통과압축식무화기흡입이락전렬소10μg,우흡약전즉각(T_0)、흡약완필후즉각,흡약완필후5、15、30화60min시감측심솔、우방압、폐소동맥설압、평균폐동맥압、평균뇨동맥압、폐혈관조력화체순배조력、심수출량급혼합정맥혈양포화도.결과 선천성심장병교치술환자체외순배후존재폐동맥고압환자28례.여흡약전즉각비교,흡약완필후각시점환자평균폐동맥압화폐혈관조력명현강저,심수출량화흡약완필후즉각、5 min시혼합정맥혈양포화도명현승고(P<0.05혹0.01).결론 체외순배결속후흡입이락전렬소가유효강저선천성심장병교치술환자폐동맥압화폐혈관조력,유조우환자안전、순리지탈리체외순배.
Objective To evaluate the effects of inhaled iloprost on pulmonary hypertension after cardiopulmonary bypass in patients with congenital heart disease undergoing surgical correction of anomaly. Methods Fifty-eight patients with congenital heart disease aged 14-60 yr undergoing surgical correction of anomaly under cardiopulmonary bypass (CPB) were enrolled in this study. Radial artery was cannulated before induction of anesthesia. A 6-lumen pulmonary catheter was placed via right internal jugular vein after tracheal intubation. Their mean pulmonary arterial pressure was still > 25 mm Hg after operation. ECG, HR, BP, CO, PAP and SpO_2 were continuously monitored. Aerosolized iloprost 10 fig was inhaled via nebulizer after CPB. Hemodynamics were measured before iloprost inhalation (baseline) and at 0, 5, 15, 30 and 60 min after the end of iloprost inhalation. Results There were 28 patients with pulmonary hypertension after CPB among the 58 patients with congenital heart disease. Inhalation of iloprost 10μg significantly decreased mPAP, pulmonary vascular resistance and intrapulmonary shunt as compared with the baseline. Iloprost inhalation could also improve significantly CO and the mixed venous oxygen saturation (SvO_2 ). Conclusion Iloprost inhaled after CPB can effectively reduce pulmonary arterial pressure and pulmonary vascular resistance in patients with congenital heart disease undergoing surgical correction of anomaly and help them wean from CPB.